Tag: The Medicines Company

ACC 2017: Positive final results from ORION-1 phase II study of inclisiran

The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORI...

The Medicines Company announces positive 180-day results for PCSK9 inhibitor

The Medicines Company has announced positive top-line results from the interim analysis with 180-day...

AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results from ORION-1 phase 2 study of their PCSK9 inhibitor inclisiran

The Medicines Company and Alnylam Pharmaceuticals have announced positive results from the analysis ...

Positive top-line results for The Medicines Company’s PCSK9si

Data from the interim analysis of the ongoing ORION-1 study, which is evaluating The Medicines Compa...

Data for The Medicines Company’s PCSK9si will be presented at AHA

Interim analysis results from ORION-1, which is evaluating The Medicines Company’s PCSK9si drug, wil...